Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
22.63
+0.63 (2.86%)
Feb 5, 2025, 2:54 PM EST - Market open
Enliven Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$37.80
Upside
+67.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +85.59% | Dec 13, 2024 |
| Baird | Baird | Buy Maintains $32 → $40 | Buy | Maintains | $32 → $40 | +76.76% | Nov 15, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +59.08% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +63.50% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +63.50% | Sep 9, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +41.41% | Jun 11, 2024 |
| Mizuho | Mizuho | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +50.24% | Apr 9, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +19.31% | Mar 29, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 3, 2023 |